Max Healthcare Institute Limited's Nomination and Remuneration Committee (NRC) approved the grant of 3,61,827 stock options under its Employee Stock Option Scheme 2022 (MHIL ESOP - 2022) in its meeting held on August 13, 2026. The meeting commenced at 7:50 AM IST and concluded at 8:20 AM IST.
The grant consists of two distinct tranches:
Tranche 1:
- Number of options granted: 1,61,827
- Exercise price: ₹800 per stock option
- Underlying shares: 1,61,827 equity shares of face value ₹10 each
Tranche 2:
- Number of options granted: 2,00,000
- Exercise price: ₹350 per stock option
- Underlying shares: 2,00,000 equity shares of face value ₹10 each
Vesting Schedule: Options will vest subject to fulfillment of pre-vesting conditions, not earlier than 1 year and not later than 5 years from the date of grant, as per terms determined by the NRC.
Exercise Period: Options may be exercised within 3 years from the respective date of vesting.
Regulatory Compliance: The scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. This disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additional Information: The stock options are governed under MHIL ESOP - 2022, which is administered and implemented by the Nomination and Remuneration Committee. The disclosure will be hosted on the company's website at www.maxhealthcare.in.
Additional Announcements:
No additional corporate updates were provided in this filing beyond the ESOP grant details.